These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11449745)

  • 61. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.
    Humphreys K; Moos RH
    Alcohol Clin Exp Res; 2007 Jan; 31(1):64-8. PubMed ID: 17207103
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Utilization and cost impact of integrating substance abuse treatment and primary care.
    Parthasarathy S; Mertens J; Moore C; Weisner C
    Med Care; 2003 Mar; 41(3):357-67. PubMed ID: 12618639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment for substance use disorders in a privately insured population under managed care: costs and services use.
    Greenfield SF; Azzone V; Huskamp H; Cuffel B; Croghan T; Goldman W; Frank RG
    J Subst Abuse Treat; 2004 Dec; 27(4):265-75. PubMed ID: 15610828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Hazards, tactics and constraints of evaluation of health care in low income countries].
    Audibert M
    C R Biol; 2008 Dec; 331(12):1007-15. PubMed ID: 19027702
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new day: strategies for managing psychiatric and substance abuse benefits.
    Fuller MG
    Health Care Manage Rev; 1994; 19(4):20-4. PubMed ID: 7896549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monitoring change in behavioral health care. The role of the Center for Mental Health Services.
    Teich JL
    Psychiatr Clin North Am; 2000 Jun; 23(2):297-308, vi-vii. PubMed ID: 10909109
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Seeking sane solutions: managing mental health and chemical dependency costs.
    Pflaum BB
    Empl Benefits J; 1991 Sep; 16(3):31-5, 40. PubMed ID: 10170846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of family-based substance abuse treatment.
    Morgan TB; Crane DR
    J Marital Fam Ther; 2010 Oct; 36(4):486-98. PubMed ID: 21039660
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Health economic evaluations help inform payers of the best use of scarce health care resources.
    O'Reilly D; Gaebel K; Xie F; Tarride JE; Goeree R
    Int J Circumpolar Health; 2011 Sep; 70(4):417-27. PubMed ID: 21924008
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
    Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
    J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Economic evaluation of adolescent addiction programs: methodologic challenges and recommendations.
    Homer JF; Drummond MF; French MT
    J Adolesc Health; 2008 Dec; 43(6):529-39. PubMed ID: 19027640
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost sharing for substance abuse and mental health services in managed care plans.
    Hodgkin D; Horgan CM; Garnick DW; Merrick EL
    Med Care Res Rev; 2003 Mar; 60(1):101-16. PubMed ID: 12674022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How expensive are unlimited substance abuse benefits under managed care?
    Sturm R; Zhang W; Schoenbaum M
    J Behav Health Serv Res; 1999 May; 26(2):203-10. PubMed ID: 10230147
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spending on mental health and substance abuse treatment, 1987-1997.
    Mark TL; Coffey RM; King E; Harwood H; McKusick D; Genuardi J; Dilonardo J; Buck JA
    Health Aff (Millwood); 2000; 19(4):108-20. PubMed ID: 10916964
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Managed care. Economic evaluation. Necessity, possibilities and limits].
    Oberender P
    Fortschr Med; 1997 May; 115(14):38-40. PubMed ID: 9264970
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Costs of family planning programmes in fourteen developing countries by method of service delivery.
    Barberis M; Harvey PD
    J Biosoc Sci; 1997 Apr; 29(2):219-33. PubMed ID: 9881132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic review.
    Jacob V; Qu S; Chattopadhyay S; Sipe TA; Knopf JA; Goetzel RZ; Finnie R; Thota AB;
    J Ment Health Policy Econ; 2015 Mar; 18(1):39-48. PubMed ID: 25862203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Perspectives. Substance abuse treatment not a priority for most health plans.
    Jordahl G
    Faulkner Grays Med Health; 1996 Jul; 50(28):suppl 1-4. PubMed ID: 10172671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.